Medical telemonitoring could be a significant lever for improving access to care and the cost-effectiveness of patient management, particularly for chronic conditions, by reducing hospital admissions. It also appears to be an opportunity to redesign the healthcare pathway and its organisation in a way that is suited to the demographic, economic, and technical challenges that our healthcare system must address. In order to prepare for the future of socialised financing of telemonitoring at the end of the ETAPES programme, participants at the round table worked on nine recommendations, based on an analysis of international literature and the French healthcare system. The main stance endorsed is the implementation of a fixed rate fee associated with the creation of generic guidelines for the diseases currently involved in the ETAPES trials. Similarly, the implementation of an evaluation that is appropriate for telemonitoring devices and of incentives for quality of care seems necessary for the sustainable deployment of telemonitoring in France. Further studies will be required in addition to the points discussed by the round table in order to delve deeper into certain topics, such as therapeutic support for patients.Le texte complet de cet article est disponible en PDF.
Keywords : Telehealth, Telemedicine, Medical telemonitoring, Healthcare organisation, Funding
|☆|| Articles, analyses and proposals for Giens workshops are those of the authors and do not prejudice the proposition of their parent organization.
Vol 75 - N° 1P. 43-56 - janvier 2020 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement ou un achat à l’unité.
L'accès au texte intégral de cet article nécessite un abonnement ou un achat à l'unité.